Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Uveitis
100%
Ocular Tuberculosis
44%
Meta-Analysis
36%
Systematic Review
36%
Tuberculosis
28%
Retinal Vasculitis
28%
Iridocyclitis
21%
Treatment Outcome
19%
Eye Inflammation
18%
Ocular Toxoplasmosis
15%
Polymerase Chain Reaction
14%
Diseases
13%
Inflammation
12%
Clinical Feature
12%
Corneal Ulcer
12%
Eye Infection
12%
Cytomegalovirus
12%
Corneal Ulcer
12%
Retrospective Cohort Study
10%
Oral
10%
Dry Eye
10%
Sarcoidosis
9%
Patient Referral
9%
Ophthalmology
9%
Interferon Gamma Release Assay
8%
Amnion
8%
COVID-19
8%
Tuberculosis Diagnosis
8%
Keratoplasty
8%
Infection
7%
Choroiditis
7%
Visual Acuity
7%
Retrospective Study
6%
Clinical Management
6%
Observational Study
6%
Pathogen
6%
Phacoemulsification
6%
Ulcer
5%
Antiviral Therapy
5%
Intermediate Uveitis
5%
Cross Sectional Study
5%
Varicella Zoster Virus
5%
Herpes Simplex Virus
5%
Visual Impairment
5%
Eye Injury
5%
Aqueous Humor
5%
Treatment Response
5%
Recurrence Risk
5%
Keyphrases
Uveitis
65%
Mycobacterium Tuberculosis (M. tb)
32%
Indonesia
31%
Ocular Tuberculosis
29%
Antitubercular Therapy
20%
Meta-analysis
20%
Retinal Vasculitis
16%
Tubercular Uveitis
15%
Infectious Uveitis
13%
Clinical Features
10%
Consensus Guidelines
10%
Ocular Inflammation
9%
Anterior Uveitis
9%
Polymerase Chain Reaction
8%
Cytomegalovirus Retinitis
8%
Collaborative Ocular Tuberculosis Study
8%
Tuberculosis Diagnosis
8%
Retinal pigment Epithelium
8%
Uveitis Treatment
8%
Treatment Algorithm
8%
Current Practice Patterns
8%
Proliferative Vitreoretinopathy
8%
Corneal Ulcer
8%
Cytomegalovirus Anterior Uveitis
8%
Interferon-gamma Release Assay
8%
Retinal pigment Epithelial Cells
7%
Anti-tubercular Treatment
6%
Inflammation
6%
Dry Eye
6%
Indonesian
6%
Antiretroviral Therapy
6%
Phacoemulsification
6%
Panuveitis
5%
Blindness
5%
Ocular Toxoplasmosis
5%
Polymerase Chain Reaction Analysis
5%
Autoimmune
5%
Systemic Inflammatory Response
5%
Quantitative PCR
5%
Clinical Characteristics
5%
Inflammation Resolution
5%
Clinical Management
5%
Aqueous Humor
5%